ja, doesnt make sense. They had a good run for a while but wheels are coming off now. Tough space to operate in.
But if you compare the 2012 results to 2013, and take out R 171m for the deconsolidation of biovac in 2012, then the comprehensive income are R13.4m for 2013 and R25.2m for 2012. So the business still running as usual, also they had a forex loss for the quater but a net gain for the year ended 2013. Wwith management cutting costs and restructuring I rate profit will only climb in future, so nows the time to buy.